European equities traded in the US as American depositary receipts were moving sharply lower Wednesday morning, falling 1.39% to 1,402.95 on the S&P Europe Select ADR Index.
Gainers in continental Europe were led by biopharmaceutical companies Genfit (GNFT) and DBV Technologies (DBVT), which climbed 11% and 7.8% respectively. They were followed biopharmaceutical company by argenx (ARGX) and internet advertising firm Criteo (CRTO), which increased 4.5% and 1.8% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Grifols (GRFS), which fell 7.5% and 5.1% respectively. They were followed by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Cellectis (CLLS), which dropped 4.6% and 3.4% respectively.
In the UK and Ireland, the only gainers were biotech firm Trinity Biotech (TRIB) and pharmaceutical company GSK (GSK), which rose 1.2% and 0.01% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Biodexa Pharmaceuticals (BDRX), which lost 5% and 4.6% respectively. They were followed by cruise line operator Carnival (CUK) and gas and electricity provider National Grid (NGG), which were down 4% and 3.9% respectively.
Comments